O'Byrne Jason

Insider profile

Performance

Overall performance
0.5

Performance over holding periods
0.5
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
O'Byrne Jason's trades of Vir Biotechnology, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
240.89
Quantity 58,540
Value US$1,632,926
Transaction date
Proposed sale
Price
343.29
Quantity 74,622
Value US$4,955,299
Transaction date
Proposed sale
Price
233.83
Quantity 95,998
Value US$2,307,449
Transaction date
Proposed sale
Price
9.90
Quantity 14,352
Value US$142,124
Transaction date
Proposed sale
Price
9.81
Quantity 25,000
Value US$245,297
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-17 2026-09-17 PrS Proposed sale
58,540
240.89
US$1,632,926
58,540 240.89 US$1,632,926
2026-09-09 2026-09-09 PrS Proposed sale
74,622
343.29
US$4,955,299
74,622 343.29 US$4,955,299
2026-08-25 2026-08-25 PrS Proposed sale
95,998
233.83
US$2,307,449
95,998 233.83 US$2,307,449
2026-08-24 2026-08-24 PrS Proposed sale
14,352
9.90
US$142,124
14,352 9.90 US$142,124
2026-08-21 2026-08-21 PrS Proposed sale
25,000
9.81
US$245,297
25,000 9.81 US$245,297
2026-02-26 2026-02-24 PlS Planned sale
1,634 -1.0%
9.53
US$15,576
1,634 -1.0% 9.53 US$15,576
2026-02-24 2026-02-24 PrS Proposed sale
1,634
9.53
US$15,576
1,634 9.53 US$15,576
2026-02-24 2026-02-23 PlS Planned sale
2,089 -1.3%
7.45
US$15,569
2,089 -1.3% 7.45 US$15,569
2026-02-23 2026-02-23 PrS Proposed sale
2,089
7.45
US$15,569
2,089 7.45 US$15,569
2025-11-18 2025-11-17 S Sale
6,799 -5.8%
5.56
US$37,782
6,799 -5.8% 5.56 US$37,782
2025-11-17 2025-11-17 PrS Proposed sale
6,799
5.56
US$37,781
6,799 5.56 US$37,781